The Patent Finder

Trillium Therapeutics ULC

Also on record
Records under this name other than patents Trillium Therapeutics ULC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 6 of 6 · Back to Trillium Therapeutics ULC

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,969,789Treatment of CD47+ Disease Cells with SIRP Alpha-FC Fusions
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,906,954Treatment of CD47+ Disease Cells with SIRP Alpha-FC Fusions
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 11,446,315Enhancement of CD47 Blockade Therapy by Proteasome Inhibitors
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,779,631Improvements in CD47 Blockade Therapy by Hdac Inhibitors
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,771,764CD47 Blockade with Radiation Therapy
Formerly held
In force
 · High confidence
In forceHigh confidence
US 12,178,803CD47 Blockade with Parp Inhibition for Disease Treatment
Formerly held
In force
 · High confidence
In forceHigh confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited